The Covid-19 mainly targets nasal epithelial cells for proliferation in the early stage of infection, a joint research team said Friday.The interim conclusion came when the exact mechanism of infection has not been revealed even after the pandemic lasted for more than 18 months since the outbreak.Re
LG Chem said Thursday that phase 2 clinical trials of its gout therapy candidate, LC350189, in the United States have met primary and secondary endpoints and showed potential as a new drug.The company said it administered LC350189 to the trial subjects once a day to inhibit xanthine oxidase (XO) exp
A consortium of Korean companies to develop and manufacture a Korean-made messenger RNA vaccine against Covid-19 officially launched Tuesday. However, industry watchers raised questions about the detailed roles of the participating companies.The Ministry of Health and Welfare and the Korea Pharmaceu
Boehringer Ingelheim Korea said that it has appointed Martín Corcoll, a healthcare expert with more than 15 years of service in Mexico and Germany, as its new chief executive officer effective on July 1.New CEO Corcoll, who graduated from the University of San Andrés in Argentina with a degree in bu
Moderna’s Covid-19 vaccine formed neutralizing antibodies against all virus variants first identified in South Africa, India, Nigeria, Uganda, and Angola. However, the neutralizing titers were reduced 2.1 to 8.4 folds against the variants compared to the original strain, the company said.On Tuesday,
HLB Pharmaceutical has introduced positive results of four studies of its gastric cancer drug, rivoceranib, branded as Apatanib in China, at the online congress hosted by the European Society for Medical Oncology (ESMO).The results of studies showing complete responses will be published as poster sl
Sanofi Aventis is strengthening its position in the local dyslipidemia treatment market with Praluent (ingredient: alirocumab), a treatment for patients with high-risk cardiovascular diseases, armed with high efficacy data for Koreans, the company said Wednesday.The prevalence of hypercholesterolemi
Sanofi’s fixed ratio co-formulation (FRC) antidiabetic drug Soliqua (ingredient: insulin glargine, lixisenatide) proved the effect of weight control and blood sugar reduction in a head-to-head comparison study against premixed insulin, the company said.The company released the results of the phase-3
Bio and health company inno.N said it submitted a registration of securities to the Financial Services Commission Wednesday to enter the process of an initial public offering in earnest.The company aims to raise at least 505.8 billion won ($447 million) via IPO by early August. It plans to offer 10.
The Korea Advanced Institute of Science and Technology (KAIST) said Tuesday that its research team has developed a self-assembling protein-based, nano-structured vaccine to prevent infectious diseases, including influenza, effectively. A KAIST research team, led by Professor Jon Sang-yong of the Dep
ST Pharm said Tuesday that it has signed a consultative research agreement with Pohang University of Science and Technology (POSTECH) to develop ways to mass-manufacture lipid nanoparticle (LNP)-based capsulized mRNA vaccines.Under the accord, researchers of POSTECH's Center for Intelligent Micropro
Ipsen’s next-generation tyrosine kinase inhibitor (TKI) Cabometyx (ingredient: cabozantinib) in combination with an immune checkpoint inhibitor failed to provide longer overall survival (OS), compared to Bayer’s Nexavar (sorafenib) in the first-line treatment of hepatocellular carcinoma (HCC).On Mon
Huons Global said that a consortium led by the company would manufacture Sputnik Light, a single-dose version of Russia’s Covid-19 vaccine Sputnik V.The Huons Global Consortium recently completed final discussions with the Russian Direct Investment Fund (RDIF) on the local production of Sputnik Ligh
JW Pharmaceutical said Monday that it has acquired exclusive rights of fostamatinib, a treatment for thrombocytopenia, from Japan’s Kissei Pharmaceutical to develop and market the drug in Korea, strengthening its hemato-oncology portfolio.The company also plans to receive orphan drug status from the
Novo Nordisk has diversified the product line of semaglutide to fight against Lilly’s GIP/GLP-1 dual agonist tirzepatide that has a strong hypoglycemic effect in the diabetes treatment market.After releasing the oral semaglutide (brand name: Rybelsus), Novo Nordisk recently tested a high-dose semagl
Korean companies donated large sums of money to the Vietnamese government's request for contributing to funds to purchase Covid-19 vaccines to inoculate its citizens.Samsung Electronics was the first Korean company to make a donation to Vietnam. According to the Vietnamese government and local indus
Bridge Biotherapeutics said Monday that the U.S. Food and Drug Administration (FDA) has requested the company to provide results proving the safety of its idiopathic pulmonary fibrosis drug candidate BBT-877 to conduct phase 2 clinical trials.The FDA recommended that the company submit further resul
inno.N said it has licensed out injection technology for its gastroesophageal reflux disease (GERD) therapy, K-CAB, to Shandong Luoxin Pharmaceutical Group, a Chinese pharmaceutical company.Under the accord, inno.N will receive royalties from Luoxin after its launch in China, and Luoxin will have ex
Researchers at the Korea Institute of Science and Technology (KIST) and Korea Research Institute of Bioscience & Biotechnology (KRIBB) have discovered the principle of decomposing tau protein, pointed out as a strong cause of dementia, through autophagy.“According to an analysis of the current statu
Genexine said Friday that it had applied for a patent for a plasmid DNA-based self-amplifying mRNA hybrid vaccine technology developed jointly with its local partner, SL Vaccigen.The technology will be applied to the future development of various vaccines, including the Covid-19 jab, the company sai